BIOCUREX INC - FORM 8-K - January 8, 2013

• SEC Filings Search:

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


       Date of Report (date of earliest event reported): December 31, 2012



                                 BIOCUREX, INC.
                        ---------------------------------
                 (Name of Small Business Issuer in its charter)

      Texas                          0-26947                  75-2742601
---------------------           ------------------        ------------------
(State or other jurisdiction   (Commission File No.)      (IRS Employer
of incorporation)                                         Identification No.)


                           7080 River Road, Suite 215
                   Richmond, British Columbia , Canada V6X 1X5
          (Address of Principal Executive Offices, including Zip Code)


       Registrant's telephone number, including area code: (866) 884-8669




                                       N/A
                    -----------------------------------------
          (Former name or former address if changed since last report)





                                       1





Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.

     On  December  31, 2012 Gladys  Chan  resigned  as the  Company's  Principal
Financial and  Accounting  Officer.  Ms. Chan's  resignation  was not due to any
disagreement   with  the  Company  on  any  matter  relating  to  the  Company's
operations, policies or practice.





                                       2






                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: January 7, 2012

                                     BIOCUREX, INC.


                                     By:/s/ Ricardo Moro
                                        -------------------------------------
                                        Dr. Ricardo Moro, President